Hashimoto's Thyroiditis, Thyroid Nodules and Cervical Drainage DysfunctionA Neurovascular–Lymphatic Model of Thyroid Inflammatory Persistence

Dr Graham Exelby 2026

Abstract

Hashimoto's thyroiditis and thyroid nodules are traditionally viewed as manifestations of autoimmune and endocrine disease arising from genetic susceptibility, environmental triggers, loss of immune tolerance, thyroid autoantibody production, and progressive glandular dysfunction. While these mechanisms remain central to disease pathogenesis, they incompletely incorporate the regional venous and lymphatic anatomy upon which normal thyroid physiology depends.

The thyroid is a highly vascular organ that drains through the superior, middle, and inferior thyroid veins into the internal jugular and brachiocephalic venous systems, while extensive deep cervical lymphatic pathways converge at the jugular–subclavian venous angle.¹˒² These drainage pathways lie within a mechanically vulnerable anatomical region influenced by cervical posture, thoracic outlet restriction, connective tissue disorders, fascial tension, internal jugular compression, and impaired lymphatic flow.

We propose that impaired cervical venous and lymphatic drainage may act as important amplifiers of thyroid inflammation and disease persistence in susceptible individuals. Within this framework, venous dysfunction preferentially promotes congestion, hypoxia, oxidative stress, endothelial activation, HIF signalling, VEGF expression, and IL-6/JAK/STAT3-mediated inflammatory persistence. Lymphatic dysfunction preferentially impairs antigen and debris clearance, promoting chronic lymphoid activation, thyroid autoantibody persistence, fibrosis, cyst formation, and thyroid nodularity.³˒¹⁰

STAT3 is positioned as a central integrative node linking inflammatory cytokines, hypoxia, angiogenesis, fibrosis, endothelial dysfunction, and chronic autoimmune persistence. Existing molecular studies in Hashimoto's thyroiditis and Graves' disease demonstrate enrichment of IL-6/JAK/STAT3 signalling, Th17/Treg dysregulation, HIF pathways, oxidative stress mechanisms, and fibro-inflammatory remodelling.⁴⁻⁸ These observations provide biological support for the proposed model.

The hypothesis additionally offers a potential explanation for the frequent coexistence of Hashimoto's thyroiditis, thyroid nodules, cervical lymphadenopathy, dysautonomia, postural orthostatic tachycardia syndrome (POTS), connective tissue disorders, and other neurovascular syndromes. Enlarged cervical lymph nodes are recognised features of Hashimoto's thyroiditis and occur within the same deep cervical drainage pathways responsible for thyroid lymphatic clearance.¹¹˒¹² Preliminary clinical observations further suggest that restoration of lymphatic drainage may transiently influence thyroid function tests, raising the possibility that some biochemical fluctuations reflect dynamic changes in inflammatory trafficking, antigen mobilisation, and tissue clearance rather than progression of thyroid failure alone.

We propose that Hashimoto's thyroiditis and thyroid nodules may represent regional manifestations of a broader neurovascular–lymphatic dysfunction in which impaired venous outflow and lymphatic clearance sustain inflammatory signalling, immune persistence, and glandular remodelling. This systems-based model integrates anatomy, vascular physiology, lymphatic biology, neuroimmune regulation, and endocrine dysfunction into a unified framework that generates testable predictions for future research.

1. Introduction

Autoimmune thyroid disease is conventionally explained through genetic susceptibility, environmental triggers, immune dysregulation, and thyroid-directed autoantibody formation. Graves’ disease and Hashimoto’s thyroiditis are both classified as autoimmune thyroid disorders characterised by loss of self-tolerance to thyroid antigens, lymphocyte infiltration, and circulating thyroid antibodies.⁹

This immune-centred model is valid but incomplete. It does not adequately explain:

• marked fluctuation in thyroid function over short timeframes,

• dynamic inflammatory activity,

• cervical lymph node activation,

• nodular and pseudonodular evolution,

• Graves-associated hypervascularity,

• coexistence with dysautonomia and connective tissue disorders,

• or the persistence of antibody production despite biochemical stabilisation.

The missing domain may be anatomy.

The thyroid resides within a confined cervical compartment and depends upon efficient drainage through:

• the internal jugular venous system,

• thoracic inlet,

• deep cervical lymphatics,

• and jugular lymphatic trunks.

These same pathways are vulnerable to:

• internal jugular vein compression,

• thoracic outlet syndrome,

• altered cervical lordosis,

• sternocleidomastoid and scalene tension,

• connective tissue laxity,

• inflammatory fibrosis,

• and chronic postural dysfunction.

We propose that autoimmune thyroid disease may, in susceptible individuals, behave as a mechanically amplified immune disorder in which impaired cervical venous and lymphatic drainage sustains inflammatory signalling, antigen persistence, hypoxia, oxidative stress, STAT3 activation, and chronic autoimmune persistence.

This model does not suggest that mechanical obstruction alone causes autoimmune thyroid disease. Rather, it proposes that mechanical venous and lymphatic dysfunction may amplify and perpetuate autoimmune thyroid disease in genetically and environmentally susceptible individuals.  

Figure 1. Venous and Lymphatic Drainage Pathways of the Thyroid

The thyroid gland possesses one of the richest vascular supplies in the body and depends upon efficient venous and lymphatic drainage through the superior, middle and inferior thyroid veins, the internal jugular veins, brachiocephalic veins and deep cervical lymphatic system. The close anatomical relationship between thyroid drainage pathways and the internal jugular–thoracic inlet region makes the gland potentially vulnerable to impaired venous outflow and lymphatic congestion. Obstruction at the level of the internal jugular vein, thoracic outlet, venous angle or deep cervical lymphatic pathways may increase interstitial pressure, impair inflammatory and antigen clearance, promote tissue hypoxia, and sustain chronic immune activation. Within the proposed model, venous dysfunction preferentially drives congestion, hypoxia and inflammatory signalling, whereas lymphatic dysfunction promotes antigen persistence, fibrosis, nodularity and chronic lymphoid activation.

Source. Arrangoiz, R. , Cordera, F. , Caba, D. , Muñoz, M. , Moreno, E. and de León, E. (2018) Comprehensive Review of Thyroid Embryology, Anatomy, Histology, and Physiology for Surgeons. International Journal of Otolaryngology and Head & Neck Surgery, 7, 160-188. doi: 10.4236/ijohns.2018.74019.

Figure Summary

This anatomical illustration demonstrates the intimate relationship between thyroid drainage pathways and the cervical venous system. The superior and middle thyroid veins drain directly into the internal jugular vein, while the inferior thyroid veins empty into the brachiocephalic venous system. Deep cervical lymphatics follow similar pathways before terminating at the jugular–subclavian venous angle. Consequently, dysfunction affecting the internal jugular veins, thoracic outlet, venous angle or cervical lymphatics may impair thyroid clearance and create a local environment characterised by venous congestion, lymphatic stagnation, oxidative stress and persistent immune activation. The model proposes that these mechanisms contribute to the development of Hashimoto's thyroiditis, thyroid nodules, cyst formation and chronic inflammatory thyroid remodelling in susceptible individuals.

2. Anatomical Vulnerability of the Thyroid

The thyroid possesses one of the richest vascular supplies in the body and relies upon continuous high-volume venous and lymphatic drainage.

Venous drainage occurs through:

• superior thyroid veins → internal jugular vein,

• middle thyroid veins → internal jugular vein,

• inferior thyroid veins → brachiocephalic venous system.¹

Lymphatic drainage involves:

• prelaryngeal nodes,

• pretracheal nodes,

• paratracheal nodes,

• and lower deep cervical lymph nodes.¹˒²

The deep cervical lymphatic system drains adjacent to the internal jugular vein and ultimately converges near the jugular–subclavian venous angle.²

This anatomy places thyroid drainage directly within the biomechanical influence of:

• thoracic outlet restriction,

• cervical posture,

• clavicular compression,

• SCM and scalene tension,

• fascial fibrosis,

• stylojugular compression,

• and altered cervical lordosis.

Consequently, cervical venous and lymphatic compromise may plausibly alter:

• thyroid interstitial pressure,

• inflammatory clearance,

• antigen trafficking,

• endothelial function,

• and regional immune signalling.

3. Venous Obstruction and Thyroid Inflammatory Signalling

3.1 Venous congestion as a hypoxic-inflammatory amplifier

Venous obstruction is not simply a drainage problem. Sustained venous impedance may produce:

• raised capillary hydrostatic pressure,

• interstitial oedema,

• endothelial activation,

• impaired oxygen extraction,

• tissue hypoxia,

• oxidative stress,

• and vascular permeability.

The proposed venous sequence is:  IJV/TOS obstruction → impaired thyroid venous drainage → interstitial congestion → hypoxia → HIF activation → VEGF/IL-6/STAT3 signalling → inflammatory vascular remodelling.

This framework is highly compatible with Graves’ disease biology, where oxidative stress, HIF-1α, VEGF-A, endothelial activation, and fibro-inflammatory remodelling are already recognised.⁷˒⁸

3.2 STAT3 as the venous–immune integration node

STAT3 is a critical convergence point linking:

• IL-6 signalling,

• Th17 differentiation,

• oxidative stress,

• hypoxia signalling,

• VEGF-mediated angiogenesis,

• fibrosis,

• endothelial activation,

• and chronic inflammatory persistence.

Transcriptomic analysis of Hashimoto’s thyroiditis tissue demonstrates enrichment of IL-6/JAK/STAT3, interferon-α, interferon-γ, and inflammatory-response pathways.⁴

Th17/Treg dysregulation is increasingly recognised as central to autoimmune thyroid disease, particularly in relation to IL-6-dependent STAT3 signalling.⁵˒⁶

This places STAT3 precisely where the model predicts:downstream of inflammatory cytokines and hypoxia, but upstream of immune persistence, angiogenesis, fibrosis, and tissue remodelling.

3.3 Pericytes as a Potential Integrator of Venous and Immune Dysfunction

Pericytes are specialised mural cells that surround capillaries and small venules, where they play essential roles in microvascular stability, endothelial signalling, regulation of capillary blood flow, angiogenesis, tissue repair, and inflammatory responses.¹³˒¹⁴ Although the role of pericytes has been extensively investigated in the brain, retina, kidney, and other highly vascular tissues, their potential contribution to thyroid disease has received relatively little attention.

Pericytes have been identified within thyroid microvascular networks where they contribute to capillary stability and regulation of local perfusion.

Within the proposed model, pericytes may represent a critical interface between venous congestion, tissue hypoxia, endothelial dysfunction, and chronic inflammatory persistence. Sustained impairment of thyroid venous drainage may increase capillary hydrostatic pressure, interstitial oedema, oxidative stress, and local hypoxia. These conditions are known to activate HIF-dependent pathways and promote production of VEGF, IL-6, and other inflammatory mediators that influence endothelial–pericyte communication.¹⁵˒¹⁶

Under physiological conditions, endothelial cells and pericytes function as a coordinated microvascular unit. Disruption of this relationship may result in altered capillary permeability, impaired regulation of local blood flow, abnormal angiogenesis, and progressive tissue remodelling. Experimental studies in other organs demonstrate that chronic inflammatory and hypoxic environments can promote pericyte dysfunction, detachment, phenotypic transition, and fibrosis, contributing to persistent tissue injury and maladaptive repair.¹⁴˒¹⁷

The thyroid gland possesses one of the richest capillary networks in the body and is therefore highly dependent upon intact microvascular regulation. Within this context, persistent venous congestion and lymphatic dysfunction may not simply alter drainage, but may also affect the behaviour of thyroid pericytes and the surrounding microcirculation.

Importantly, the molecular pathways already implicated in Hashimoto's thyroiditis and Graves' disease—including IL-6/JAK/STAT3 signalling, HIF activation, oxidative stress, VEGF-mediated angiogenesis, and fibro-inflammatory remodelling—are also recognised regulators of pericyte biology.¹⁵˒¹⁸ Consequently, pericytes may represent an important mechanistic link between regional vascular dysfunction and the glandular fibrosis, nodularity, hypervascularity, and structural remodelling observed in autoimmune thyroid disease.

Within the broader neurovascular–lymphatic framework proposed here, pericytes may therefore function as local amplifiers of disease persistence, integrating haemodynamic stress, inflammatory signalling, endothelial dysfunction, and tissue repair responses. Further investigation of thyroid microvascular architecture and endothelial–pericyte interactions may provide important insights into the mechanisms underlying Hashimoto's thyroiditis, thyroid nodules, and chronic thyroid inflammatory remodelling.

Figure 2. The Neurovascular–Lymphatic–Pericyte Model of Thyroid Remodelling

This figure illustrates the proposed neurovascular–lymphatic–pericyte model of thyroid remodelling. Impaired cervical venous and lymphatic drainage may promote venous congestion and lymphatic stasis within the thyroid microenvironment. These processes converge upon endothelial–pericyte dysfunction, a critical regulatory interface responsible for maintaining microvascular stability, capillary perfusion, and tissue adaptation. Persistent endothelial–pericyte dysfunction may activate hypoxia-responsive and inflammatory pathways including HIF, VEGF, and IL-6/JAK/STAT3 signalling, driving fibrosis, lymphoid organisation, angiogenesis, extracellular matrix remodelling, and chronic inflammatory persistence. The model predicts that differing balances between venous congestion and lymphatic dysfunction may produce distinct thyroid phenotypes ranging from hypervascular Graves-like states to Hashimoto's thyroiditis, thyroid nodularity, cyst formation, and progressive fibrotic remodelling.

4. Graves’ Disease as a Venous-Inflammatory Output

Graves’ disease may represent one potential hypervascular and inflammatory-dominant expression.

Unlike Hashimoto’s thyroiditis, which often progresses toward fibrosis and lymphoid persistence, Graves’ disease demonstrates:

• gland hypervascularity,

• stimulatory antibody signalling,

• inflammatory oedema,

• and in some patients, orbitopathy.

Graves’ thyroid and orbitopathy tissue have been linked to oxidative stress and hypervascularisation through the NOX4/HIF-1α/VEGF-A pathway and STAT3-dependent miR-199a regulation.⁷

STAT3 has additionally been proposed as a therapeutic target in Graves’ orbitopathy because of its role in inflammation, oxidative stress, fibroblast activation, and adipogenesis.⁸

These findings strongly support the molecular pathways predicted by a venous-hypoxic inflammatory model:

• oxidative stress,

• HIF-1α,

• VEGF,

• endothelial activation,

• STAT3 signalling,

• and fibro-inflammatory remodelling.

In susceptible individuals, cervical venous congestion could therefore plausibly amplify Graves’ disease by increasing hypoxia, vascular activation, and inflammatory persistence.

5. Lymphatic Dysfunction, Hashimoto's Thyroiditis and Thyroid Nodularity

5.1 Hashimoto’s as a lymphatic-persistence disorder

Hashimoto’s thyroiditis is characterised by:

• lymphocytic infiltration,

• thyroid follicular destruction,

• autoantibody formation,

• germinal centre development,

• and progressive fibrosis.³

The lymphatic system is essential for:

• interstitial fluid clearance,

• antigen trafficking,

• immune surveillance,

• inflammatory resolution,

• and extracellular debris removal.

If thyroid lymphatic drainage becomes impaired, retained thyroid antigens such as thyroid peroxidase (TPO) and thyroglobulin may remain exposed to immune surveillance pathways for prolonged periods. This may promote:

• dendritic activation,

• lymphoid aggregation,

• persistent antibody generation,

• chronic T-cell stimulation,

• and fibrosis.

Importantly, lymphatic vessels have been demonstrated within lymphoid infiltrates in Hashimoto thyroids, and tertiary lymphoid structures are recognised features of autoimmune thyroiditis.¹⁰ This strongly supports the concept that Hashimoto’s is not simply an endocrine gland failure state, but an immune-lymphatic tissue remodelling disorder.

5.2 Cervical lymph nodes in Hashimoto’s

Hashimoto’s thyroiditis is associated with increased numbers of enlarged cervical lymph nodes, particularly in levels III and IV.¹¹˒¹²

This observation is highly relevant because levels III and IV lie directly along the jugular chain and lower cervical drainage pathways — precisely where internal jugular obstruction and thoracic inlet mechanics become clinically important.

This supports a key anatomical inference that Hashimoto’s is regionally expressed through the cervical lymphatic system, not isolated within the thyroid gland alone.

In patients with impaired cervical lymphatic drainage or venous outlet restriction, this regional lymphatic activation may become less efficient, more congested, and more persistent.

5.3 Thyroid Nodules as a Manifestation of Regional Clearance Failure

Thyroid nodules are traditionally considered focal proliferative lesions arising from genetic, inflammatory, endocrine and environmental influences. However, the striking association between Hashimoto's thyroiditis, multinodular thyroid change and chronic cervical inflammatory states suggests that impaired tissue clearance may also contribute.

Persistent lymphatic dysfunction may reduce the removal of cellular debris, oxidised proteins, inflammatory mediators and thyroid antigens from the gland. Concurrent venous congestion may increase interstitial pressure, tissue hypoxia, endothelial activation and local growth factor signalling. Together these processes may promote fibrosis, follicular remodelling, pseudonodular change, cyst formation and true nodular development.

Within the proposed model, thyroid nodules represent not merely focal structural abnormalities but regional manifestations of chronic inflammatory persistence occurring within a mechanically vulnerable drainage environment.

6. Venous versus Lymphatic Dominance: A Proposed Clinical Distinction

A clinically useful distinction may exist between venous-dominant and lymphatic-dominant autoimmune thyroid signatures.

6.1 Venous-dominant thyroid inflammatory state

Predicted features:

• glandular hypervascularity,

• inflammatory swelling,

• vascular pulsatility,

• fluctuating thyroid hormone output,

• Graves-like vascular behaviour,

• pressure sensitivity,

• HIF/VEGF signatures.

Dominant pathway: Venous obstruction → congestion → hypoxia → HIF-1α/HIF-2α → VEGF → IL-6/STAT3 → vascular-inflammatory remodelling.

This pattern may be more relevant to Graves’ disease, inflammatory thyroid hypervascularity, and orbitopathy.

6.2 Lymphatic-dominant thyroid persistence state

Predicted features:

• persistent TPO/Tg antibodies,

• cervical lymphadenopathy,

• nodules,

• cysts,

• pseudonodules,

• fibrosis,

• fluctuating gland texture,

• chronic inflammatory persistence.

Dominant pathway: Lymphatic obstruction → impaired antigen/debris clearance → dendritic activation → lymphoid follicle persistence → antibody generation → fibrosis and nodularity.

This pattern may be more relevant to Hashimoto’s thyroiditis and chronic fibrotic thyroid remodelling.

Many patients likely demonstrate mixed venous–lymphatic signatures.

Table 1. Proposed Clinical Signatures of Thyroid Drainage Dysfunction

Clinical Feature	Venous-Dominant Pattern	Lymphatic-Dominant Pattern
Thyroid vascularity	Increased	Normal or mildly increased
Graves-like features	Common	Uncommon
Neck pressure/fullness	Common	Variable
Hypervascular ultrasound	Common	Uncommon
Fluctuating thyroid function	Common	Moderate
TPO/Tg persistence	Moderate	High
Cervical lymphadenopathy	Moderate	High
Thyroid nodules	Moderate	High
Thyroid cysts	Moderate	High
Fibrosis	Moderate	High
Pseudonodules	Moderate	High
Tissue texture fluctuation	Moderate	High
Dysautonomia overlap	Common	Common
POTS association	Common	Common
Proposed dominant mechanism	Congestion–Hypoxia–STAT3	Clearance Failure–Antigen Persistence

6.3 Clinical Exemplar of Neurovascular–Lymphatic Thyroid Dysfunction

A clinically illustrative case involved a 39-year-old female with longstanding Hashimoto’s thyroiditis, dysautonomia, bilateral stylojugular compression, venous thoracic outlet syndrome, loss of cervical lordosis, chronic sensitisation, and preload failure physiology documented on autonomic and echocardiographic assessment.

The patient demonstrated symptomatic improvement following cervical stabilisation therapy and manual lymphatic drainage. However, shortly after a lymphatic mobilisation session, thyroid-stimulating hormone (TSH) rose abruptly despite ongoing clinical improvement. Baseline TSH 2.7 mIU/L increased to 13 mIU/L following lymphatic mobilisation before spontaneously normalising to 1.1 mIU/L two weeks later without thyroxine dose escalation.

This sequence was considered difficult to reconcile with simple progressive thyroid gland failure. Instead, it raised the possibility that restoration of lymphatic flow transiently altered inflammatory trafficking, cytokine mobilisation, or thyroid antigen exposure.

The patient additionally demonstrated:

• marked upright preload reduction,

• collateralised cranial venous drainage,

• autonomic fragmentation,

• and impaired postural renin–aldosterone activation,

• supporting broader neurovascular and drainage dysfunction rather than isolated endocrine pathology.

While a single case cannot establish causation, this observation illustrates the physiological convergence predicted by the proposed neurovascular–lymphatic model of autoimmune thyroid disease.

7. Integration with Dysautonomia and Neurovascular Disease

Hashimoto's thyroiditis and thyroid nodules frequently coexist with dysautonomia, postural orthostatic tachycardia syndrome (POTS), connective tissue disorders, chronic fatigue syndromes, migraine, mast-cell-associated inflammatory states, and other neurovascular conditions. While these associations are often considered coincidental or secondary to shared autoimmune predisposition, an alternative explanation may exist within the framework of regional venous and lymphatic dysfunction.

Many of these disorders demonstrate evidence of impaired venous return, preload reduction, autonomic instability, altered cervical biomechanics, and disturbed lymphatic drainage. Increasing evidence suggests that the cervical venous and lymphatic systems function not as isolated anatomical structures but as components of a broader neurovascular regulatory network linking cerebral perfusion, autonomic control, immune surveillance, and tissue homeostasis.

Within this model, impaired cervical venous drainage may contribute to brainstem perfusion instability through effects on cerebral venous outflow, intracranial compliance, glymphatic clearance, and regional haemodynamics. The brainstem contains critical autonomic regulatory centres including the nucleus tractus solitarius, dorsal motor nucleus of the vagus, locus coeruleus, and associated cardiorespiratory control networks. Dysfunction within these regions may influence vascular tone, endocrine regulation, inflammatory signalling, and autonomic adaptation.

The thyroid is highly sensitive to autonomic and neuroendocrine influences. Sympathetic activity affects thyroid blood flow, hormone release, and vascular regulation, while hypothalamic–pituitary signalling governs thyroid-stimulating hormone secretion. Consequently, chronic disturbances in autonomic regulation may amplify local thyroid pathology through altered vascular control, inflammatory signalling, and neuroendocrine modulation.

An additional consideration is the frequent coexistence of preload failure physiology in patients with dysautonomia. Reduced venous return, impaired orthostatic compensation, and abnormal renin–aldosterone responses may reflect broader disturbances in vascular regulation extending beyond the thyroid itself. Within the proposed framework, cervical venous obstruction, thoracic outlet restriction, and impaired lymphatic drainage may contribute simultaneously to autonomic dysfunction, cerebral perfusion instability, and thyroid inflammatory persistence.

This integrated perspective may help explain why Hashimoto's thyroiditis, thyroid nodules, cervical lymphadenopathy, migraine, fatigue syndromes, connective tissue disorders, and dysautonomia frequently cluster within the same patients. Rather than representing unrelated conditions, these disorders may reflect different regional manifestations of a shared neurovascular–lymphatic dysfunction involving impaired drainage, inflammatory persistence, altered autonomic regulation, and tissue remodelling.

Importantly, this hypothesis does not propose that dysautonomia causes thyroid disease, nor that thyroid disease causes dysautonomia. Rather, both may arise from overlapping disturbances affecting cervical venous outflow, lymphatic clearance, neuroimmune signalling, and physiological adaptation. Future studies examining thyroid disease alongside autonomic profiling, vascular imaging, preload physiology, and lymphatic assessment may help clarify these relationships.

8. Research Predictions

This hypothesis generates several testable predictions.

Patients with autoimmune thyroid disease, particularly those with dysautonomia or cervical symptoms, may show increased prevalence of:

• internal jugular vein compression,

• thoracic outlet syndrome,

• altered cervical lymphatic drainage,

• cervical lymph node enlargement,

• abnormal dynamic thyroid vascularity,

• thoracic inlet congestion,

• and impaired venous drainage on positional ultrasound.

The model predicts future identification of:

• venous-dominant autoimmune thyroid signatures,

• and lymphatic-dominant autoimmune thyroid signatures

  
  

  on ultrasound, vascular imaging, autonomic profiling, and inflammatory phenotyping.

8.1 Dynamic Thyroid Responses Following Restoration of Venous and Lymphatic Flow

An additional prediction of the proposed neurovascular–lymphatic model is that restoration of impaired cervical venous or lymphatic drainage may produce transient alterations in thyroid function tests that do not necessarily represent progression of intrinsic thyroid failure.

Clinical observations within our cohort have identified patients with Hashimoto's thyroiditis, dysautonomia, cervical venous obstruction, and impaired lymphatic drainage who developed temporary elevations in thyroid-stimulating hormone (TSH) following manual lymphatic therapy, despite ongoing clinical improvement and subsequent spontaneous normalisation of thyroid function without escalation of thyroid hormone replacement.

Within the proposed model, restoration of lymphatic flow may transiently alter:

·       inflammatory cytokine trafficking

·       thyroid antigen clearance

·       lymphatic drainage of immune complexes

·       interstitial fluid dynamics

·       regional tissue oxygenation

·       neuroendocrine signalling

Potential mechanisms include mobilisation of retained inflammatory mediators, transient changes in thyroid interstitial pressure, altered antigen presentation, and short-term perturbation of hypothalamic–pituitary–thyroid axis regulation.

This hypothesis predicts that some fluctuations in thyroid function tests may represent dynamic tissue remodelling and restoration of physiological clearance pathways rather than progressive thyroid gland failure alone.

Prospective studies incorporating serial thyroid function testing before and after lymphatic interventions, together with inflammatory markers, thyroid antibodies, cervical ultrasound, and vascular assessment, may help determine whether these observations represent a reproducible physiological phenomenon.

9. Clinical Implications

This model does not replace conventional endocrine management.  Thyroxine replacement, antithyroid therapy, radioactive iodine, surgery, and standard endocrine monitoring remain essential where clinically indicated.

However, in selected patients with:

• dysautonomia,

• cervical venous obstruction,

• thoracic outlet syndrome,

• fluctuating thyroid physiology,

• head pressure,

• or lymphatic congestion,

assessment may benefit from expansion beyond static endocrine markers.

Potential adjunctive assessments include:

• thyroid ultrasound with vascularity assessment,

• cervical lymph node mapping,

• dynamic internal jugular ultrasound,

• thoracic outlet venous assessment,

• cervical posture/lordosis evaluation,

• autonomic profiling,

• and inflammatory/metabolic assessment.

Potential adjunctive strategies may include:

• cervical physical assessment and management,

• thoracic outlet rehabilitation,

• lymphatic mobilisation,

• posture restoration,

• inflammatory modulation,

• oxidative stress reduction,

• and targeted STAT3/HIF pathway investigation.

These interventions should be considered upstream stabilisation approaches, not replacements for endocrine care.

10. Conclusion

Hashimoto's thyroiditis and thyroid nodules are traditionally viewed as manifestations of autoimmune and endocrine disease. While genetic susceptibility, environmental triggers, immune dysregulation, and thyroid autoantibodies remain fundamental components of disease pathogenesis, these models incompletely incorporate the anatomical and physiological realities of thyroid drainage.

The thyroid is a highly vascular organ whose venous and lymphatic outflow depends upon efficient drainage through the internal jugular veins, brachiocephalic venous system, deep cervical lymphatics, and jugular–subclavian venous angle. These pathways lie within a mechanically vulnerable region influenced by cervical posture, thoracic outlet restriction, connective tissue disorders, fascial tension, internal jugular compression, and impaired lymphatic flow.

We propose that, in susceptible individuals, impaired cervical venous and lymphatic drainage may act as an important amplifier of thyroid inflammation and disease persistence. Within this framework, venous dysfunction preferentially promotes congestion, hypoxia, oxidative stress, HIF activation, endothelial dysfunction, VEGF signalling, and IL-6/JAK/STAT3-mediated inflammatory persistence. In contrast, lymphatic dysfunction preferentially impairs antigen and debris clearance, promoting chronic lymphoid activation, antibody persistence, fibrosis, nodularity, cyst formation, and progressive glandular remodelling.

This model provides a potential anatomical explanation for the frequent coexistence of Hashimoto's thyroiditis, thyroid nodules, cervical lymphadenopathy, dysautonomia, POTS, connective tissue disorders, and neurovascular syndromes. Rather than representing unrelated comorbidities, these conditions may reflect different regional manifestations of a shared neurovascular–lymphatic dysfunction.

Importantly, preliminary clinical observations suggest that restoration of lymphatic drainage may itself influence thyroid physiology. Transient alterations in thyroid function testing following lymphatic interventions raise the possibility that some biochemical fluctuations may reflect changing inflammatory trafficking, antigen mobilisation, interstitial pressure dynamics, or restoration of physiological clearance pathways rather than simple progression of thyroid failure. Although these observations remain preliminary, they generate important and testable research questions regarding the relationship between thyroid function, inflammation, and regional drainage physiology.

Within this integrated framework, Hashimoto's thyroiditis and thyroid nodules may be viewed not solely as disorders of autoimmunity or endocrine dysfunction, but as dynamic disorders occurring within a broader system involving venous drainage, lymphatic clearance, neuroimmune regulation, vascular biology, and tissue adaptation.

Future research incorporating thyroid imaging, cervical vascular assessment, lymphatic evaluation, autonomic profiling, inflammatory biomarkers, and serial thyroid function testing may help determine the extent to which impaired regional drainage contributes to thyroid disease initiation, persistence, and recovery. If confirmed, this model may provide a new systems-based framework for understanding thyroid disease and identify novel opportunities for earlier recognition and upstream intervention.

References

1. Allen E, Fingeret A. Anatomy, Head and Neck, Thyroid. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.

2. Koroulakis A, Jamal Z, Agarwal M. Anatomy, Head and Neck, Lymph Nodes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

3. Kaur J, et al. Hashimoto Thyroiditis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.

4. Zheng L, et al. Bioinformatics analysis of key genes and pathways in Hashimoto thyroiditis tissues. Biosci Rep. 2020;40(7):BSR20200759.

5. Wang Y, et al. Pathogenic role of Th17 cells in autoimmune thyroid disease. Best Pract Res Clin Endocrinol Metab. 2023.

6. Shao S, et al. Autoimmune thyroid diseases and Th17/Treg lymphocytes. Life Sci. 2018;192:160-165.

7. Craps J, et al. miR-199a downregulation as a driver of the NOX4/HIF-1α/VEGF-A pathway in Graves’ disease and Graves’ orbitopathy. Int J Mol Sci. 2021;23(1):153.

8. Ko JS, et al. Signal transducer and activator of transcription 3 as a therapeutic target in Graves’ orbitopathy. J Endocrinol Invest. 2021.

9. Antonelli A, et al. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174-180.

10. Furtado GC, et al. Lymphotoxin β receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. Proc Natl Acad Sci USA. 2007;104(12):5026-5031.

11. Jones MR, et al. The presentation of lymph nodes in Hashimoto’s thyroiditis on ultrasound. Gland Surg. 2015;4(4):301-306.

12. Brancato D, et al. Neck lymph nodes in chronic autoimmune thyroiditis. Endocr Pathol. 2013;24(1):15-22.

13. Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21(2):193-215.

14. Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signalling pathways. Nat Neurosci. 2016;19(6):771-783.

15. Teichert M, Milde L, Holm A, et al. Pericyte-expressed Tie2 controls angiogenesis and vessel maturation. Nat Commun. 2017;8:16106.

16. Caporarello N, D'Angeli F, Cambria MT, et al. Pericytes in microvessels: from "mural" function to regulation of signalling and inflammation. Biomedicines. 2019;7(4):77.

17. Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in kidney fibrosis. Am J Pathol. 2008;173(6):1617-1627.

18. Nikolakopoulou AM, Montagne A, Kisler K, Dai Z, Wang Y, Huuskonen MT, et al. Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss. Nat Neurosci. 2019;22(7):1089-1098